Abstract
Bisphosphonates are widely used in the management of osteoporosis. They are cleared rapidly from the circulation, with about half the administered dose taken up by the skeleton and the rest excreted unmetabolized by the kidneys.1 At the bone surface, bisphosphonates suppress bone resorption and are embedded in bone. The embedded bisphosphonate is released slowly from bone, presumably after the resumption of bone remodeling at previously exposed sites.